1) Gertz MA, et al. Secondary systemic amyloidosis : response and survival in 64 patients. Medicine (Baltimore). 1991 ; 70 : 246-256.
2) 豊島元. 剖検輯報からみた慢性関節リウマチの死因-とくにアミロイドーシスとの関連から-. リウマチ 1993 ; 33 : 209-214.
3) 北浜真理子, 他. AAアミロイドーシス臨床像の年代別変化. リウマチ学会 2007プログラム・抄録集. 2007 ; p.282.
4) Okuda Y, et al. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Intern Med. 2018 ; 57 : 3351-3355.
5) Lane T, et al. Changing epidemiology of AA amyloidosis : clinical observations over 25 years at a single national referral centre. Amyloid. 2017 ; 24 : 162-166.
6) Okuda Y, et al. Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis. 1997 ; 56 : 535-541.
7) Looi LM. Histomorphological variations in systemic AA amyloidosis : clue of AA protein polymorphism. Histopathology. 1989 ; 14 : 111-120.
8) Uda H, A, et al. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol. 2006 ; 33 : 1482-1487.
9) Verine J, et al. Clinical and histological characteristics of renal AA amyloidosis : a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol. 2007 ; 38 : 1798-1809.
10) Ueno T, et al. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis. Nephrol Dial Transplant. 2012 ; 27 : 633-639.
11) Tiitinen S, et al. Amyloidosis-incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol. 1993 ; 22 : 158-161.
12) Tanaka F, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003 ; 21 : 343-346.
13) 奥田恭章. リウマチ医が知るべき関節リウマチの臓器合併症-その診断・治療・予防 二次性アミロイドーシス (反応性AAアミロイドーシス). リウマチ科 2011 ; 46151 : 501-509.
14) Kuroda T, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol. 2006 ; 25 : 498-505.
15) Kofman T, et al. Renal transplantation in patients with AA amyloidosis nephropathy : results from a French multicenter study. Am J Transplant. 2011 ; 11 : 2423-2431.
16) 奥田恭章. 慢性関節リウマチに合併した2次性アミロイドーシス124例の臨床的検討-胃十二指腸生検による診断と予後を中心として-. リウマチ 1994 ; 34 : 939-946.
17) Kuroda T, et al. Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheumatol. 2002 ; 21 : 123-128.
18) Gillmore JD, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001 ; 358 : 24-29.
19) Gottenberg JE, et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides : a followup report of tolerability and efficacy. Arthritis Rheum. 2003 ; 48 : 2019-2024.
20) Fernandez-Nebro A, et al. Long-term TNF-alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. Am J Med. 2010 ; 123 : 454-461.
21) Okuda Y, et al. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. Mod Rheumatol. 2014 ; 24 : 137-143.
22) Okuda Y, et al. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum. 2006 ; 54 : 2997-3000.
23) Nishida S, et al. Rapid improvement of AA amyloidosis with humanized anti-interleukin 6 receptor antibody treatment. Ann Rheum Dis. 2009 ; 68 : 1235-1236.
24) 奥田恭章. AAアミロイドーシス合併関節リウマチ症例におけるアミロイド蛋白のターンオーバーと除去. 別冊・医学のあゆみ アミロイドーシス UPDATE 2010. pp35-38.
25) Kuroda T, et al. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment. Rheumatol Int. 2006 ; 26 : 1147-1153.
26) 奥田恭章. 関節リウマチに伴うAAアミロイドーシス. 胃と腸 2014 ; 49 : 335-343.